Global Botanical And Plant-Derived Drugs Market to grow by USD 18.66 billion during 2024-2029 - Technavio

Regional Market Trends

The report details how Botanical Drug Trends propel the Botanical and Plant-Derived Drugs Market regionally.

• United States: North America’s hub, leading with Botanical Drugs like Taxol, backed by FDA and a wellness.
• China: APAC’s giant, driving Plant-Derived Pharmaceuticals like Artemisinin with government-supported Phytomedicine.
• India: Ayurveda fuels Herbal Supplements and Botanical Extracts for chronic conditions.
• Germany: Europe’s leader, thriving with Herbal Drug Manufacturers like Schwabe and regulated Natural Drug Products.
• United Kingdom: Steady growth with Natural Remedies and botanical research investments.
• Other Regions: Japan innovates with Kampo Traditional Medicine, Brazil taps Amazonian Ethnobotany, and the Middle East and Africa grow with awareness.

Explore regional Botanical Market Growth. Download Sample Report Now.

Market Segments and Subsegments

The Botanical and Plant-Derived Drugs Market segments highlight its drivers.

By Application:

• Infectious Diseases: Features Natural Drug Products like Quinine.
• Central nervous system
• Cardiovascular diseases
• Respiratory diseases
• Others

By Geography:

• APAC: Largest share, led by China and India’s Herbal Medicine.
• North America: Strong US growth in Plant Drug Development.
• Europe: Steady in Germany and the UK with regulated Herbal Drug Market.

See how segments boost Botanical Market Size. Download Sample Today.

Market Dynamics: Drivers, Trends, and Challenges

The Botanical and Plant-Derived Drugs Market evolves with key forces.

Drivers:

• Government Support: China and India promote Plant-Based Therapies.
• Biotech: Advances enhance Botanical Drugs efficacy in the US.
• Consumer Shift: Demand for Herbal Supplements grows globally.

Trends:

• AI: Speeds up Plant Drug Development in North America and Europe.
• Sustainability: Eco-friendly Botanical Extracts rise in Germany.
• Standardization: Quality control strengthens Herbal Drug Market trust in APAC.

Challenges:

• Regulations: Europe’s strict rules slow Botanical Innovations.
• Supply Issues: Variability challenges Natural Drug Products in South America.
• Skepticism: Physicians resist Traditional Medicine in some areas.

Navigate these dynamics. Download Sample Report.

Key Players

The Herbal Drug Market thrives with Herbal Drug Manufacturers like:

• Bausch Health Companies Inc.
• Bayer AG
• Boehringer Ingelheim International GmbH
• Dr. Willmar Schwabe GmbH and Co. KG
• Jaguar Health Inc.
• Jazz Pharmaceuticals Plc
• Medigene AG
• Novartis AG
• Pfizer Inc.
• Pierre Fabre SA
• Sanofi SA
• Sun Pharmaceutical Industries Ltd.

These firms lead with Botanical Innovations and R&D.

Green Future for Botanical Drugs

The Botanical and Plant-Derived Drugs Market’s USD 18.66 billion growth by 2029 underscores its healthcare role. APAC dominates, with North America and Europe steady behind. Botanical Drugs lead applications, while Plant-Derived Drugs expand reach. With AI-driven Plant Drug Development and sustainable Ethnobotany, the market meets modern needs, despite regulatory hurdles.

About Technavio

Technavio offers insights across 800 technologies and 50 countries. With 500+ analysts and 17,000+ reports, it empowers businesses in markets like the Botanical and Plant-Derived Drugs Market.